Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Henry

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|June 18, 2021
Discovery of Anti-SS-A Antibodies during Stroke Investigations in Young Adults: What Impact?Soledad Henriquez, Nicolas Legris, Pascale Chrétien, et al.
RMD Open|November 2, 2019
Anti-RNP positivity in primary Sjögren's syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvementSalam Abbara, Raphaele Seror, Julien Henry, et al.
Joint Bone Spine|June 19, 2021
Denosumab in active Charcot neuro-osteoarthropathy of the footSandrine Carvès, Muriel Bourgeon-Ghittori, Julien Henry, et al.
JBMR Plus|April 22, 2024
Complete remission after a single bisphosphonate infusion in isolated bone Langerhans cell histiocytosis lesion: a case report and a narrative review of the literatureAlexandra Kachaner, Raphaèle Seror, Fleur Cohen Aubart, et al.
Bone Reports|April 5, 2024
High rate of progression to symptomatic multiple myeloma in patients with smoldering myeloma and isolated osteoporotic vertebral fractureKevin Chevalier, Sabrina Hamroun, Samuel Bitoun, et al.
Clinical and Experimental Rheumatology|December 19, 2022
Changes of anti-citrullinated peptide antibodies titers after biologic treatment in patients with rheumatoid arthritis: a systematic literature review and retrospective studyStéphane Hilliquin, Julia Herrou, Loriane Gutermann, et al.
Rheumatology (Oxford, England)|December 22, 2017
Doses of rituximab for retreatment in rheumatoid arthritis: influence on maintenance and risk of serious infectionJulien Henry, Jacques-Eric Gottenberg, Stéphanie Rouanet, et al.
Rheumatology (Oxford, England)|October 16, 2019
Immunization to rituximab is more frequent in systemic autoimmune diseases than in rheumatoid arthritis: ofatumumab as alternative therapyAlice Combier, Gaétane Nocturne, Julien Henry, et al.
Haematologica|March 23, 2023
Chemotherapy in solitary bone plasmacytoma to prevent evolution to multiple myelomaSophia Ascione, Stéphanie Harel, Florent L Besson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 12, 2017
<sup>18</sup>F-FDG PET/CT of extensive rheumatoid nodulosisVictoire Roblot, Julien Henry, Céline Meyer, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|June 18, 2021
Discovery of Anti-SS-A Antibodies during Stroke Investigations in Young Adults: What Impact?Soledad Henriquez, Nicolas Legris, Pascale Chrétien, et al.
RMD Open|November 2, 2019
Anti-RNP positivity in primary Sjögren's syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvementSalam Abbara, Raphaele Seror, Julien Henry, et al.
Joint Bone Spine|June 19, 2021
Denosumab in active Charcot neuro-osteoarthropathy of the footSandrine Carvès, Muriel Bourgeon-Ghittori, Julien Henry, et al.
JBMR Plus|April 22, 2024
Complete remission after a single bisphosphonate infusion in isolated bone Langerhans cell histiocytosis lesion: a case report and a narrative review of the literatureAlexandra Kachaner, Raphaèle Seror, Fleur Cohen Aubart, et al.
Bone Reports|April 5, 2024
High rate of progression to symptomatic multiple myeloma in patients with smoldering myeloma and isolated osteoporotic vertebral fractureKevin Chevalier, Sabrina Hamroun, Samuel Bitoun, et al.
Clinical and Experimental Rheumatology|December 19, 2022
Changes of anti-citrullinated peptide antibodies titers after biologic treatment in patients with rheumatoid arthritis: a systematic literature review and retrospective studyStéphane Hilliquin, Julia Herrou, Loriane Gutermann, et al.
Rheumatology (Oxford, England)|December 22, 2017
Doses of rituximab for retreatment in rheumatoid arthritis: influence on maintenance and risk of serious infectionJulien Henry, Jacques-Eric Gottenberg, Stéphanie Rouanet, et al.
Rheumatology (Oxford, England)|October 16, 2019
Immunization to rituximab is more frequent in systemic autoimmune diseases than in rheumatoid arthritis: ofatumumab as alternative therapyAlice Combier, Gaétane Nocturne, Julien Henry, et al.
Haematologica|March 23, 2023
Chemotherapy in solitary bone plasmacytoma to prevent evolution to multiple myelomaSophia Ascione, Stéphanie Harel, Florent L Besson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 12, 2017
<sup>18</sup>F-FDG PET/CT of extensive rheumatoid nodulosisVictoire Roblot, Julien Henry, Céline Meyer, et al.
Pageof 4